RNU6-1088P

Across TCGA pan-cancer cohorts, RNU6-1088P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-1088P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU6-1088P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1088P expression acts as an unfavorable survival marker, although some lineages such as CHOL show a favorable association.

KIRP, BLCA, and ACC are the cancer types where RNU6-1088P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.648	0.882	.001	33	view →
BLCA	OS	Tertile	III,IV	0.141	0.581	.011	18	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
PCPG	DFS	Tertile	All	0.094	0.768	.011	18	view →
CHOL	DFS	Tertile	All	0.755	0.322	.036	9	view →
ESCA	DFS	Quartile	All	0.219	0.345	.030	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-1088P–KIRP (DFS)

Open the KIRP breakdown →